BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 25677117)

  • 21. Solid state characterization and crystal structure from X-ray powder diffraction of two polymorphic forms of ranitidine base.
    de Armas HN; Peeters OM; Blaton N; Van Gyseghem E; Martens J; Van Haele G; Van Den Mooter G
    J Pharm Sci; 2009 Jan; 98(1):146-58. PubMed ID: 18393299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure determination of the β-cyclodextrin-p-aminobenzoic acid inclusion complex from powder X-ray diffraction data.
    Guo P; Su Y; Cheng Q; Pan Q; Li H
    Carbohydr Res; 2011 May; 346(7):986-90. PubMed ID: 21440247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determination of the stable and meta-stable forms of atomoxetine HCl using single crystal and powder X-ray diffraction methods.
    Stephenson GA; Liang C
    J Pharm Sci; 2006 Aug; 95(8):1677-83. PubMed ID: 16732589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cynarine monohydrate from synchrotron powder X-ray diffraction data.
    Kaduk JA; Boaz NC; Markun EL; Gindhart AM; Blanton TN
    Acta Crystallogr C Struct Chem; 2022 Feb; 78(Pt 2):101-106. PubMed ID: 35119388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray powder diffraction structure determination of gamma-butyrolactone at 180 K: phase-problem solution from the lattice energy minimization with two independent molecules.
    Papoular RJ; Allouchi H; Chagnes A; Dzyabchenko A; Carré B; Lemordant D; Agafonov V
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):312-20. PubMed ID: 15914896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
    Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
    Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
    Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
    J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe anhydrate, determined from laboratory powder diffraction data.
    Brüning J; Alig E; Schmidt MU
    Acta Crystallogr C; 2010 Jul; 66(Pt 7):o341-4. PubMed ID: 20603561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indexing powder patterns in physical form screening: instrumentation and data quality.
    Florence AJ; Baumgartner B; Weston C; Shankland N; Kennedy AR; Shankland K; David WI
    J Pharm Sci; 2003 Sep; 92(9):1930-8. PubMed ID: 12950010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pushing the Limits of Molecular Crystal Structure Determination From Powder Diffraction Data in High-Throughput Chemical Environments.
    Kabova EA; Blundell CD; Shankland K
    J Pharm Sci; 2018 Aug; 107(8):2042-2047. PubMed ID: 29679705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular structure of a D-homoandrostanyl steroid derivative: single crystal and powder diffraction analyses.
    Martinetto P; Terech P; Grand A; Ramasseul R; Dooryhée E; Anne M
    J Phys Chem B; 2006 Aug; 110(31):15127-33. PubMed ID: 16884225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Lysine: exploiting powder X-ray diffraction to complete the set of crystal structures of the 20 directly encoded proteinogenic amino acids.
    Williams PA; Hughes CE; Harris KD
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3973-7. PubMed ID: 25651303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice.
    Henry R; Zhang GG
    J Pharm Sci; 2007 May; 96(5):1251-7. PubMed ID: 17455320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis.
    Martí-Rujas J; Kawano M
    Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second SH3 domain of ponsin solved from powder diffraction.
    Margiolaki I; Wright JP; Wilmanns M; Fitch AN; Pinotsis N
    J Am Chem Soc; 2007 Sep; 129(38):11865-71. PubMed ID: 17784760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular versus crystal symmetry in tri-substituted triazine, benzene and isocyanurate derivatives.
    Chong SY; Seaton CC; Kariuki BM; Tremayne M
    Acta Crystallogr B; 2006 Oct; 62(Pt 5):864-74. PubMed ID: 16983167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of a novel sodium ion channel blocker.
    Cheung EY; Harris KD; Johnston RL; Hadden KL; Zakrzewski M
    J Pharm Sci; 2003 Oct; 92(10):2017-26. PubMed ID: 14502541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure Determination and Characterization of a Family of Primary Alcohol Solvates.
    Vasudevan KV; Peterson ML
    J Pharm Sci; 2018 Jun; 107(6):1489-1497. PubMed ID: 29421220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.